Startup CytoScale Diagnostics to Commercialize UCLA's Single-Cell Protein Biomarker Platform

The platform can detect proteins in samples as small as 1,000 cells, potentially offering an approach for biomarker discovery and diagnostic work using highly limited tissue sources, said one of its developers.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.